Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Fletcher

Showing results (111-120 of 112) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 112 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic TumorsAslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
Journal of Medicinal Chemistry|September 9, 2010
Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agentsSteven Fletcher, Erin Pusateri Keaney, Christopher G Cummings, et al.
Pageof 12

Showing results (111-120 of 112) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 112 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic TumorsAslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
Journal of Medicinal Chemistry|September 9, 2010
Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agentsSteven Fletcher, Erin Pusateri Keaney, Christopher G Cummings, et al.
Pageof 12